Prevalence of p53 and p21 Expression in Colorectal Cancer: A Histopathologic Study from Iran
- 15 June 2012
- journal article
- Published by Science Alert in Journal of Biological Sciences
- Vol. 12 (5), 327-331
- https://doi.org/10.3923/jbs.2012.327.331
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Expression of Membranous Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma and It ’ s Correlation with Clinicopathological FeaturesPakistan Journal of Biological Sciences, 2011
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk FactorsClinics in Colon and Rectal Surgery, 2009
- Inherent Resistance to Epidermal Growth Factor Receptor Antibodies in Refractory Metastatic Colorectal CancerJournal of Medical Sciences, 2009
- Association Between p53 Expression and Bcl-2, P-glycoprotein, Topoisomerase II Alpha, Thymidylate Synthase and Thymidine Phosphorylase as Potential Therapeutic Targets in Colorectal Cancer PatientsPakistan Journal of Biological Sciences, 2007
- Level of the Expression of VEGF-A, B, C, D and their Receptors (FLT-1, KDR and FLT-4) and its Correlation with Prognosis in Patients with Colorectal CancerInternational Journal of Cancer Research, 2005
- Correlation Between Thymidine Phosphorylase Expression and Sex of Patients in Colorectal CarcinomaInternational Journal of Cancer Research, 2004
- p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?International Journal of Colorectal Disease, 2001
- Prognostic impact of p21/waf1/cip1 in colorectal cancerInternational Journal of Cancer, 2000
- p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutationsThe Journal of Pathology, 1999